cor2ed
engage checkpoint medical linkedin twitter
bg

NTRK gene fusions, TRK inhibitors and testing approaches BluePrint

NTRK gene fusions, TRK inhibitors and testing approaches BluePrint

Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager

NTRK CONNECT identified NTRK Gene Fusions on the ESMO OncologyPro portal as a practical guide on how to test for NTRK gene fusions and treat with TRK inhibitors.
Portrait of Andrea Sartore-Bianchi
Prof. Andrea Sartore-Bianchi

Medical Oncologist

Niguarda Cancer Center

Italy

Portrait of Fernando López-Ríos
Prof. Fernando López-Ríos

Pathologist

Hospital Universitario HM Sanchnarro Universidad CEU San Pablo

Spain

Portrait of Gerald Prager
Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

preview next

time BluePrint Resource | open 5 min | 2019

download resources

I agree that this educational programme:

NTRK CONNECT have now developed BluePrint documents as a reference guide providing a concise overview in downloadable formats. A variety of topics are covered including, overview of gene fusions and role as oncogenic drivers, detection approaches available, NTRK family and NTRK gene fusions, epidemiology of cancers with NTRK gene fusions and an overview of TRK inhibitors.

Prof. Andrea Sartore-Bianchi (NTRK CONNECT), Dr. Jaclyn Hechtman, Prof. Fernando Lopez-Rios (NTRK CONNECT), Assoc. Prof. Gerald Prager have developed this resource with COR2ED.

NTRK CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

Other programmes developed by Prof. Andrea Sartore-Bianchi

Portrait of Andrea Sartore-Bianchi
Prof. Andrea Sartore-Bianchi

Medical Oncologist

Niguarda Cancer Center

Italy

preview next

Other programmes developed by Prof. Fernando López-Ríos

Other programmes developed by Assoc. Prof. Gerald Prager

Portrait of Gerald Prager
Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

preview next